See the Neocate Syneo difference for yourself.
Closer to breast milk than any other amino acid‑based formula (AAF)*
Managing cow milk allergy (CMA) symptoms is a top priority. But research shows that many infants with food allergies can also have a gut microbiota that’s different from healthy breastfed infants.1-3 That’s why we created Neocate Syneo Infant, the only AAF with prebiotics, probiotics, and nucleotides—three components inspired by breast milk that help support the developing immune system.†
Hypoallergenic amino acid-based infant formula for the dietary management of food allergies, clinically shown to:
See the Neocate Syneo difference for yourself.
Inspired by three key components of breast milk,† Neocate Syneo Infant is the only hypoallergenic formula with:
These carefully selected ingredients help support the developing immune system.†
| Neocate® Syneo® Infant | Neocate® Infant DHA/ARA | Elecare® Infant7 |
Alfamino® Infant8 |
PurAmino™ Infant9 |
|
|---|---|---|---|---|---|
| Nucleotides | |||||
| Probiotics | |||||
| Prebiotic Oligosaccharides | |||||
| DHA & ARA |
The gut microbiota in early life plays a key role in the development of the immune system.10-12 Kids with CMA can have gut dysbiosis3,13-15‡—a concerning imbalance in the gut microbiota that has been linked to immune-related diseases15-18 and health problems later in life.19-24 In fact, children with CMA have been found to be up to four times more likely than healthy children to get infections.25,26
One publication suggests that gut dysbiosis increases susceptibility to infections.24 And the antibiotics used to fight infections can dramatically alter the gut microbiota,27,28 potentially worsening dysbiosis.
The pre-and probiotics in Neocate Syneo Infant help address gut dysbiosis by balancing the gut microbiota,§ so you can go beyond food allergy symptom control.1,2,4
Exploratory findings across randomized clinical trials in infants with CMA show that the immune-supporting capabilities of Neocate Syneo Infant may lead to:
Exploratory findings are results of safety evaluations, and do not intend to offer final and conclusive results. Further research is needed to confirm the findings.
This publication reports that Neocate Syneo Infant5:
This publication reports that Neocate Syneo Infant6:
This publication reports that Neocate Syneo Infant1:
This publication reports that Neocate Syneo Infant4:
This publication reports that Neocate Syneo Infant2:
This systematic review and meta-analysis reports that Neocate Syneo Infant30:
Help your patients tackle CMA with the only hypoallergenic formula that provides the power of prebiotics, probiotics, and nucleotides—inspired by breast milk.† After you submit your sample request, you’ll also be able to explore our full library of food allergy resources for healthcare professionals, including:
The content you are trying to access is intended for healthcare professionals only.
Are you a healthcare professional?